These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8580728)

  • 41. Human adhalin is alternatively spliced and the gene is located on chromosome 17q21.
    McNally EM; Yoshida M; Mizuno Y; Ozawa E; Kunkel LM
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9690-4. PubMed ID: 7937874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro.
    Liu L; Vachon PH; Kuang W; Xu H; Wewer UM; Kylsten P; Engvall E
    Biochem Biophys Res Commun; 1997 Jun; 235(1):227-35. PubMed ID: 9196068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Confocal analysis of the dystrophin protein complex in muscular dystrophy.
    Draviam R; Billington L; Senchak A; Hoffman EP; Watkins SC
    Muscle Nerve; 2001 Feb; 24(2):262-72. PubMed ID: 11180210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K
    Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Negative result in search for human alpha-dystrobrevin deficiency.
    Ishikawa H; Nonaka I; Nishino I
    Muscle Nerve; 2003 Sep; 28(3):387-8. PubMed ID: 12929204
    [No Abstract]   [Full Text] [Related]  

  • 47. [Significance of merosin and sarcoglycan in manifestations of certain forms of muscular dystrophy].
    Medić S; Rakocević-Stojanović V
    Srp Arh Celok Lek; 1998; 126(1-2):34-9. PubMed ID: 9525081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical localization of chondroitin sulfate, chondroitin sulfate proteoglycan, heparan sulfate proteoglycan, entactin, and laminin in basement membranes of postnatal developing and adult rat lungs.
    Sannes PL; Burch KK; Khosla J; McCarthy KJ; Couchman JR
    Am J Respir Cell Mol Biol; 1993 Mar; 8(3):245-51. PubMed ID: 8448015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle.
    Mizuno Y; Noguchi S; Yamamoto H; Yoshida M; Suzuki A; Hagiwara Y; Hayashi YK; Arahata K; Nonaka I; Hirai S
    Biochem Biophys Res Commun; 1994 Sep; 203(2):979-83. PubMed ID: 8093083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
    Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
    Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
    Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normal expression of adhalin and merosin in ovine congenital progressive muscular dystrophy.
    Johnsen RD; Laing NG; Huxtable CR; Kakulas BA
    Aust Vet J; 1997 Mar; 75(3):215-6. PubMed ID: 9088516
    [No Abstract]   [Full Text] [Related]  

  • 54. Deficiency of the 50 kDa dystrophin associated glycoprotein (adhalin) in severe autosomal recessive muscular dystrophies in children native from European countries.
    Fardeau M; Matsumura K; Tomé FM; Collin H; Leturcq F; Kaplan JC; Campbell KP
    C R Acad Sci III; 1993 Aug; 316(8):799-804. PubMed ID: 8044705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rare cause of high transaminasemia: autosomal muscle dystrophy with gamma sarcoglycan.
    Urganci N; Erkan T; Serdaroglu P; Oztelik G; Dogan S; Kayaalp N
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):327-9. PubMed ID: 11345186
    [No Abstract]   [Full Text] [Related]  

  • 56. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy.
    Roberds SL; Leturcq F; Allamand V; Piccolo F; Jeanpierre M; Anderson RD; Lim LE; Lee JC; Tomé FM; Romero NB
    Cell; 1994 Aug; 78(4):625-33. PubMed ID: 8069911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
    Larraín J; Alvarez J; Hassell JR; Brandan E
    Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. gamma-sarcoglycan deficiency muscular dystrophy in two adults.
    Lin KL; Wang HS; Chen ST; Ro LS
    J Formos Med Assoc; 2000 Oct; 99(10):789-91. PubMed ID: 11061077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunofluorescence study of a muscle biopsy from a 1-year-old patient with Walker-Warburg syndrome.
    Villanova M; Sabatelli P; He Y; Malandrini A; Petrini S; Maraldi NM; Merlini L
    Acta Neuropathol; 1998 Dec; 96(6):651-4. PubMed ID: 9845296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.